Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune Hemolytic anemia

J A Axelson, A F LoBuglio

    The Medical Clinics of North America
    |July 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Immune hemolytic anemia occurs when antibodies or complement proteins destroy red blood cells. The Coombs test is crucial for diagnosing this condition by detecting these substances on red cells.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.

    Cancer biotherapy & radiopharmaceuticals·2001
    Same author

    National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

    Journal of the National Cancer Institute·2001
    Same author

    Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2001
    Same author

    A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer.

    Cancer biotherapy & radiopharmaceuticals·2001
    Same author

    Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2001
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Clinical Diagnostics

    Background:

    • Immune hemolytic anemia (IHA) is an acquired condition.
    • It involves the premature destruction of red blood cells.
    • Antibody and/or complement deposition on red blood cells triggers IHA.

    Purpose of the Study:

    • To summarize the diagnostic approach to immune hemolytic anemia.
    • To highlight the role of the Coombs test in diagnosing IHA.

    Main Methods:

    • Review of diagnostic criteria for immune hemolytic anemia.
    • Emphasis on the application and evolution of the Coombs test.

    Main Results:

    • The Coombs test, in its various forms, is essential for diagnosing IHA.
  • Detection of antibody and/or complement on red blood cells confirms the diagnosis.

    • Conclusions:

    • Immune hemolytic anemia is diagnosed by identifying autoantibodies or complement on red blood cells.
    • The Coombs test remains the gold standard for diagnosing IHA.